checkAd

    IGEA Pharma N.V.  129  0 Kommentare Convening notice and Agenda “Annual Shareholder Meeting” IGEA Pharma N.V. - Seite 3



    Hoofddorp, 28 September 2023
    The Board of Directors

    Explanatory notes

    Agenda item 2 & 3:

    Approval Annual Report 2022 and proposal to adopt the annual accounts for financial year 2022

    The Company’s Annual Report 2022 has been made available on the Company’s website https://www.igeapharma.nl/category/financial-reports/ and at the office address of the Company.
     
    End of Inside Information
    Language: English
    Company: IGEA Pharma N.V.
    Siriusdreef 17
    2123 WT Hoofddorp
    Netherlands
    Phone: +31 23 568 9494
    E-mail: info@igearesearch.com
    Internet: www.igeapharma.nl
    ISIN: NL0012768675
    Listed: Regulated Unofficial Market in Frankfurt; SIX Swiss Exchange
    EQS News ID: 1736887

     
    End of Announcement EQS News Service

    1736887  28-Sep-2023 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1736887&application_name=news&site_id=wallstreet

    Lesen Sie auch

    Seite 3 von 3




    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    IGEA Pharma N.V. Convening notice and Agenda “Annual Shareholder Meeting” IGEA Pharma N.V. - Seite 3 IGEA Pharma N.V. / Key word(s): AGMEGM/AGMEGM IGEA Pharma N.V.: Convening notice and Agenda “Annual Shareholder Meeting” IGEA Pharma N.V. 28-Sep-2023 / 19:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely …